FORM 8-K

Company

Cellectar Biosciences, Inc.

Filed

August 23, 2024

Period of Report

August 20, 2024

Accession Number

0001104659-24-092495

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →